Cyclosporine in the treatment of autoimmune disorders: A 10-year experience

Transplantation Proceedings

Volumn 30, Issue 8, 1998, Pages 4134-

  Mitrovic, D ^a   Popovic, M ^a   Glisic, B ^a   Pavlica, Lj ^a   Dimitrijevic, M ^b  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CYCLOSPORIN; GOLD; LEFLUNOMIDE; METHOTREXATE; PENICILLAMINE;

AUTOIMMUNE DISEASE; BEHCET DISEASE; BRAIN VASCULITIS; CHORIORETINITIS; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE SEVERITY; DRUG EFFECT; DRUG RESPONSE; FEMALE; GINGIVA HYPERTROPHY; HUMAN; MALE; PATIENT SELECTION; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0032429350     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01369-4     Document Type: Conference Paper

References (4)

1. 1. Masuda K, Nakajama A: In Schindler R (eds): Cyclosporine in Autoimmune Diseases. Berlin: Springer-Verlag; p 162, 1985
2. 2. Mitrovic D, Popovic M, Pavlica Lj, et al: VSP 54:321, 1997
3. 3. Cassava D, Lagana B, Mitterhofer AF, et al: Arthritis Rheum 40:27, 1997
4. 4. Van den Borne BE, Landewer RB, Breedveld FC, et al: Scand J Rheumatol 25:307, 1996